UPDF AI

Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer

Simeng Wen,Yundong He,4 Authors,Haojie Huang

2020 · DOI: 10.1038/s41388-020-01456-z
Oncogene · 34 Citations

TLDR

It is demonstrated that aberrantly activated SE upregulates CHPT1 expression and confers Enz resistance in CRPC, suggesting that SE-mediated expression of downstream effectors such asCHPT1 can be viable targets to overcome EnZ resistance in PCa.